Latest stories on MXCT
MaxCyte GAAP EPS of -$0.08 beats by $0.01, revenue of $7.27M beats by $0.8M
Seeking Alpha56 · neutralearnings
MAXCYTE, INC. (MXCT) files 8-K
SEC 8-K50 · neutralgeneral
MaxCyte Reports Second Quarter 2026 Financial Results
GlobeNewswire56 · neutralearnings
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
Business Insider66 · bullishproduct/pr
MaxCyte Shareholders Reelect Directors and Ratify Auditor
TipRanks50 · neutralgeneral
MaxCyte Regains Nasdaq Compliance After Bid Price Recovery
TipRanks58 · neutralgeneral
MAXCYTE, INC. (MXCT) files 8-K
SEC 8-K34 · bearishgeneral
Here’s Why MaxCyte (MXCT) is Becoming a High-Conviction Bet for Investors
Yahoo Finance67 · bullishgeneral
Cisco, Alibaba And 3 Stocks To Watch Heading Into Wednesday
Yahoo Finance57 · neutralearnings
MaxCyte, Inc. Q1 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings